Lei Lu

Lei Lu

Auto-generated profile, based on publicly available information

Lei Lu

Department of Pharmaceutical Chemistry, University of California, San Francisco, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 October 2020 in Nature Methods
Verified
Journal Article
Closed access
PDF file
LLLei Lu
Lei Lu
NRNicholas M. Riley
Nicholas M. Riley
MSMichael R. Shortreed
Michael R. Shortreed
CBCarolyn Bertozzi
Carolyn Bertozzi
LSLloyd Smith
Lloyd Smith

5 April 2024 in Science
Verified
Journal Article
Closed access
LLLei Lu
Lei Lu
XGXuxu Gou
Xuxu Gou
STSophia K. Tan
Sophia K. Tan
SMSamuel I. Mann
Samuel I. Mann
HYHyunjun Yang
Hyunjun Yang
WDWilliam F. DeGrado
William F. DeGrado
The de novo design of small molecule–binding proteins has seen exciting recent progress; however, high-affinity binding and tunable specificity typically require laborious screening and optimization after computational design. We developed a computational procedure to design a protein that recognizes a common pharmacophore in a series of poly(ADP-ribose) polymerase–1 inhibitors. One of three designed proteins bound different inhibitors with affinities ranging from <5 nM to low micromolar. X-ray crystal structures confirmed the accuracy of the designed protein-drug interactions. Molecular dynamics simulations informed the role of water in binding. Binding free energy calculations performed directly on the designed models were in excellent agreement with the experimentally measured affinities. We conclude that de novo design of high-affinity small molecule–binding proteins with tuned interaction energies is feasible entirely from computation.

8 May 2025 in Science
Verified
Journal Article
Closed access
KHKaipeng Hou
Kaipeng Hou
WHWei Huang
Wei Huang
MQMiao Qi
Miao Qi
TTThomas H. Tugwell
Thomas H. Tugwell
TATurki M. Alturaifi
Turki M. Alturaifi
WDWilliam F. DeGrado
William F. DeGrado
De novo design of protein catalysts with high efficiency and stereoselectivity provides an attractive approach toward the design of environmentally benign catalysts. Here, we design proteins that incorporate histidine-ligated synthetic porphyrin and heme ligands. Four of 10 designed proteins catalyzed cyclopropanation with an enantiomeric ratio greater than 99:1. A second class of proteins were designed to catalyze a silicon-hydrogen insertion and were optimized by directed evolution in whole cells. The evolved proteins incorporated features unlikely to be generated by computational design alone, including a proline in an α helix. Molecular dynamics simulations showed that as the proteins evolved toward higher activity, their conformational ensembles narrowed to favor more productive conformations. Our work demonstrates that efficient de novo protein catalysts are designable and should be useful for manifold chemical processes.

25 May 2018 in Journal of Proteome Research
Verified
Journal Article
Closed access
LLLei Lu
Lei Lu
RMRobert J. Millikin
Robert J. Millikin
SSStefan K. Solntsev
Stefan K. Solntsev
ZRZach Rolfs
Zach Rolfs
MSMark Scalf
Mark Scalf
LSLloyd Smith
Lloyd Smith

7 October 2020 in Journal of Proteome Research
Verified
Journal Article
Closed access
ACAnthony J. Cesnik
Anthony J. Cesnik
RMRachel M. Miller
Rachel M. Miller
KIKhairina Ibrahim
Khairina Ibrahim
LLLei Lu
Lei Lu
RMRobert J. Millikin
Robert J. Millikin
LSLloyd Smith
Lloyd Smith

4 January 2019 in Analytical Chemistry
Verified
Journal Article
Closed access
XZXiaofang Zhong
Xiaofang Zhong
QYQinying Yu
Qinying Yu
FMFengfei Ma
Fengfei Ma
DFDustin C. Frost
Dustin C. Frost
LLLei Lu
Lei Lu
LLLingjun Li
Lingjun Li